Volver a Agenda
Session Chair(s)
Jim Zisek
Director, Global CMC Regulatory Affairs
GlaxoSmithKline, United States
Speaker(s)
Clinical Track
John E. Kraus, MD, PHD
GlaxoSmithKline Research & Development, United States
Head of Medical Governance, Neurosciences Therapy Area Unit
Nonclinical Track
James Wild, PHD, MS
FDA, United States
Pharmacologist, CDER
CMC Track
Emma Wright, PHD
NITTO DENKO Avecia Inc, United States
Senior Director, Process Development
¿Tiene una cuenta?